Metraipolis › archive › dc_ce4fab014e12

CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance — Europe PMC PMID:41122708

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41122708
DOI: 10.3389/fendo.2025.1647028
License (as archived): solo-consultazione
Archived: 2026-11-09T18:40:37.464Z
SHA-256 of the archived text: d1a4459f8fcda8cd352a693f9cdbfa5a5bb76d87045d3ffd794dad957da471fe
Stable URL of this page: https://metraipolis.com/documento/dc_ce4fab014e12

How to cite

CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance — Europe PMC PMID:41122708 — Europe PMC (en), https://europepmc.org/article/MED/41122708 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce4fab014e12 (Metraipolis archive dc_ce4fab014e12, sha256 d1a4459f8fcda8cd352a693f9cdbfa5a5bb76d87045d3ffd794dad957da471fe)

BibTeX

@misc{dcce4fab014e12,
  title = {CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance — Europe PMC PMID:41122708},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41122708},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce4fab014e12; sha256 d1a4459f8fcda8cd352a693f9cdbfa5a5bb76d87045d3ffd794dad957da471fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41122708. Agents can read the archived copy with the MCP tool read_document.